Comparison of sensitivities to two commercially available tuberculin skin test reagents in persons with recent tuberculosis

Clinical Infectious Diseases

Volumn 25, Issue 3, 1997, Pages 661-665

  Duchin, J S ^a   Jereb, J A ^b   Nolan, C M ^b   Smith, P ^b   Onorato, I M ^b  

^a PUBLIC HEALTH SEATTLE AND KING COUNTY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

REAGENT; TUBERCULIN;

ADULT; AGED; ARTICLE; BACTERIUM CULTURE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INTRADERMAL DRUG ADMINISTRATION; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TUBERCULIN TEST; TUBERCULOSIS;

EID: 0030846328     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/513771     Document Type: Article

References (15)

1. American Thoracic Society. Control of tuberculosis in the United States. Am Rev Respir Dis 1992; 146:1623-33.
2. American Thoracic Society. Diagnostic standards and classification of tuberculosis. Am Rev Respir Dis 1990; 142:725-35.
3. Edwards PQ, Edwards LB. Story of the tuberculin skin test from an epidemiologic viewpoint. Am Rev Respir Dis 1960; 81(1 Pt 2)(suppl):l-47.
4. Rupp ME, Schultz AW Jr, Davis JC. Discordance between tuberculin skin test results with two commercial purified protein derivative preparations [letter]. J Infect Dis 1994; 169:1174-5.
5. Cieslak TJ, Irwin RG, Dougherty PA, Miller GM. A pseudoepidemic of tuberculin skin test conversions caused by a particular lot of purified protein derivative of tuberculin test solution. Pediatr Infect Dis J 1995; 14:392-3.
6. Lifson AR, Watters JK, Thompson S, Crane CM, Wise F. Discrepancies in tuberculin skin test results with two commercial products in a population of intravenous drug users. J Infect Dis 1993; 168:1048-51.
7. Infectious Disease Branch, California Department of Health Services. False positive tuberculin skin test reactions and product viability. California Morbidity 1989; 28:1.
8. Section of Epidemiology, Alaska Department of Health and Social Services. False positive Aplisol PPD reactions. State Alaska Epidemiol Bull 1992; 9:1.
9. Whitaker J. Letter. J Hosp Occup Health 1993; 13:24.
10. Blackshear J, Bravo E, Gesink D, Davis SF, Iber G, Johnson JR. False positive skin tests with Parke-Davis Aplisol® [letter]. Am Rev Respir Dis 1983; 127:254.
11. O'Brien RJ, Snider DE, Cauthen GM. Hyper-reactivity of Aplisol® tuberculin [abstract]. Am Rev Respir Dis 1983; 127(4 Pt 2)(suppl):190.
12. Palmer CE, Bates LE. Tuberculin sensitivity of tuberculous patients. Bull World Health Organ 1952; 7:171-88.
13. Chaparas SD, Vandiviere HM, Melvin I, Koch G, Becker C. Tuberculin test: variability with the Mantoux procedure. Am Rev Respir Dis 1985; 132:175-7.
14. Loudon RG, Lawson RA Jr, Brown J. Variation in tuberculin test reading. Am Rev Respir Dis 1963; 87:852-61.
15. Bearman JE, Kleinman H, Glyer VV, LaCroix OM. A study of variability in tuberculin test reading. Am Rev Respir Dis 1964; 90:913-9.